Publix Offers Free Diabetes Screenings

Kate H. Gamble, Senior Editor
Published Online: Wednesday, July 27, 2011
Publix Super Markets has announced that it is offering free diabetes screenings at more than 800 Publix stores this year. Patients do not need to make appointments, and test results will be given onsite within minutes. All participants will receive a free blood glucose test and diabetes educational material.

According to the CDC, 25.8 million people in the United States have diabetes, 7 million of which are undiagnosed. In a study published last year, the CDC projected that as many as 1 in 3 US adults could have diabetes by 2050 if current trends continue.

“Publix Pharmacy is pleased to offer free diabetes screenings as part of our commitment to the total health and wellness of our customers,” said Maria Brous, director of media and community relations, in a statement. “As both a supermarket and pharmacy, Publix is the ideal setting in which to promote healthy living. Offering these free screenings will hopefully assist our customers in early detection and allow them to benefit from our diabetes program which launched last March offering free Metformin for Type II diabetes patients.”

The screenings will be conducted by Cholestcheck Corp, a health and wellness screening company, and sponsored in part by Bayer HealthCare Diabetes Care, a manufacturer of diabetes monitoring systems and other products and services designed to help simplify life for individuals with diabetes.

For a complete listing of health screenings dates and times, customers may visit and click on the “Health Screenings” link.
Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues